The role of neutrophils in osteosarcoma: insights from laboratory to clinic DOI Creative Commons
Ming Xia, Yu Han,

Lihui Sun

et al.

Frontiers in Immunology, Journal Year: 2024, Volume and Issue: 15

Published: Nov. 8, 2024

Osteosarcoma, a highly aggressive malignant bone tumor, is significantly influenced by the intricate interactions within its tumor microenvironment (TME), particularly involving neutrophils. This review delineates multifaceted roles of neutrophils, including tumor-associated neutrophils (TANs) and neutrophil extracellular traps (NETs), in osteosarcoma’s pathogenesis. TANs exhibit both pro- anti-tumor phenotypes, modulating growth immune evasion, while NETs facilitate cell adhesion, migration, immunosuppression. Clinically, neutrophil-related markers such as neutrophil-to-lymphocyte ratio (NLR) predict patient outcomes, highlighting potential for neutrophil-targeted therapies. Unraveling these complex crucial developing novel treatment strategies that harness TME to improve osteosarcoma management.

Language: Английский

Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights DOI Open Access

Linda Galasso,

Fabrizio Termite, Irene Mignini

et al.

Cancers, Journal Year: 2025, Volume and Issue: 17(3), P. 368 - 368

Published: Jan. 23, 2025

Fusobacterium nucleatum, a gram-negative anaerobic bacterium, has emerged as significant player in colorectal cancer (CRC) pathogenesis. The bacterium causes persistent inflammatory reaction the mucosa by stimulating release of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α, creating an environment conducive to progression. F. nucleatum binds penetrates epithelial cells through adhesins such FadA, impairing cell junctions encouraging epithelial-to-mesenchymal transition (EMT), which is associated with advancement. Additionally, modulates host immune system, suppressing activity conditions favorable for tumor growth. Its interactions gut microbiome contribute dysbiosis, further influencing carcinogenic pathways. Evidence indicates that can inflict DNA damage either directly via reactive oxygen species or indirectly environment. it triggers oncogenic pathways, especially Wnt/β-catenin signaling pathway, promotes growth longevity. Moreover, alters microenvironment, impacting behavior, metastasis, therapeutic responses. purpose this review elucidate molecular mechanisms contributes CRC. Understanding these crucial development targeted therapies diagnostic strategies CRC nucleatum.

Language: Английский

Citations

1

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence DOI Creative Commons
Muhammad Tufail, Canhua Jiang, Ning Li

et al.

Military Medical Research, Journal Year: 2025, Volume and Issue: 12(1)

Published: Feb. 11, 2025

Abstract Cancer recurrence, driven by the phenomenon of tumor dormancy, presents a formidable challenge in oncology. Dormant cancer cells have ability to evade detection and treatment, leading relapse. This review emphasizes urgent need comprehend dormancy its implications for recurrence. Despite notable advancements, significant gaps remain our understanding mechanisms underlying lack reliable biomarkers predicting provides comprehensive analysis cellular, angiogenic, immunological aspects dormancy. It highlights current therapeutic strategies targeting dormant cells, particularly combination therapies immunotherapies, which hold promise preventing By elucidating these proposing innovative research methodologies, this aims deepen ultimately facilitating development more effective recurrence improving patient outcomes.

Language: Английский

Citations

1

Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review) DOI Open Access

Rayan Naser,

Isabelle Fakhoury,

Adam El‐Fouani

et al.

International Journal of Oncology, Journal Year: 2022, Volume and Issue: 62(2)

Published: Dec. 27, 2022

Genetic alterations drive tumor onset and progression. However, the cross‑talk between cells benign components of surrounding stroma can also promote initiation, progression metastasis solid tumors. These cellular non‑cellular stromal form microenvironment (TME), which co‑evolves with cells. Their dynamic mutualistic interactions are currently considered to be among distinctive hallmarks cancer. Biochemical physical cues from TME serve an essential role in regulating They associated resistance treatment poor prognosis patients Therefore, a deep understanding is vital for developing potent anticancer therapeutics improving patient outcomes. The present review aims biology both constituents novel findings regarding their contribution core as well emerging cancer hallmarks. describes key markers that either targeted interventional clinical trials or promising potential therapies. Understanding intercellular toward identifying mechanisms resistance. Such utmost significance personalized effective therapy strategies.

Language: Английский

Citations

31

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens DOI Creative Commons
Nityanand Srivastava, Salman Sadullah Usmani,

Rajasekaran Subbarayan

et al.

Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13

Published: July 10, 2023

Triple-negative breast cancer (TNBC) is one of the deadliest subtypes (BC) for its high aggressiveness, heterogeneity, and hypoxic nature. Based on biological clinical observations TNBC related mortality very worldwide. Emerging studies have clearly demonstrated that hypoxia regulates critical metabolic, developmental, survival pathways in TNBC, which include glycolysis angiogenesis. Alterations to these accelerate stem cells (CSCs) enrichment immune escape, further lead tumor invasion, migration, metastasis. Beside this, also manipulates epigenetic plasticity DNA damage response (DDR) syndicate progression. Hypoxia fundamentally creates low oxygen condition responsible alteration Hypoxia-Inducible Factor-1alpha (HIF-1α) signaling within microenvironment, allowing tumors survive making them resistant various therapies. Therefore, there an urgent need society establish target-based therapies overcome resistance limitations current treatment plan TNBC. In this review article, we thoroughly discussed plausible significance HIF-1α as a target therapeutic regimens such chemotherapy, radiotherapy, immunotherapy, anti-angiogenic therapy, adjuvant therapy photodynamic adoptive cell combination therapies, antibody drug conjugates vaccines. Further, reviewed here intrinsic mechanism existing issues targeting while improvising strategies. This highlights discusses future perspectives major alternatives by hypoxia-induced signaling.

Language: Английский

Citations

22

Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC) DOI Creative Commons

Jingquan Huang,

Qiulin Wu,

David A. Geller

et al.

Journal of Translational Medicine, Journal Year: 2023, Volume and Issue: 21(1)

Published: Nov. 15, 2023

Abstract The pivotal role of the tumor microenvironment (TME) in initiation and advancement hepatocellular carcinoma (HCC) is widely acknowledged, as it fosters proliferation metastasis HCC cells. Within intricate TME HCC, tumor-associated macrophages (TAMs) represent a significant constituent non-malignant TAMs engage direct communication with cancer cells while also exerting influence on other immune to adopt tumor-supportive phenotype that facilitates progression. Among multifaceted mechanisms at play, metabolic reprogramming both leads phenotypic alterations functional modifications macrophages. This comprehensive review elucidates interplay between cellular metabolism macrophage phenotype/polarization, providing an overview associated signaling molecules potential therapeutic strategies for HCC.

Language: Английский

Citations

22

Diverse Neutrophil Functions in Cancer and Promising Neutrophil-Based Cancer Therapies DOI Open Access
Khetam Sounbuli, Н. Л. Миронова, Л. А. Алексеева

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(24), P. 15827 - 15827

Published: Dec. 13, 2022

Neutrophils represent the most abundant cell type of leukocytes in human blood and have been considered a vital player innate immune system first line defense against invading pathogens. Recently, several studies showed that neutrophils play an active role response during cancer development. They exhibited both pro-oncogenic anti-tumor activities under influence various mediators tumor microenvironment. can be divided into subpopulations, thus contradicting traditional concept as homogeneous population with specific function immunity opening new horizons for therapy. Despite promising achievements this field, full understanding tumor–neutrophil interplay is currently lacking. In review, we try to summarize current view on neutrophil heterogeneity cancer, discuss different communication pathways between tumors neutrophils, focus implementation these findings develop neutrophil-based therapies.

Language: Английский

Citations

28

Lipid metabolism in tumor microenvironment: novel therapeutic targets DOI Creative Commons

Xingkai Liu,

Ping Zhang, Jing Xu

et al.

Cancer Cell International, Journal Year: 2022, Volume and Issue: 22(1)

Published: July 5, 2022

Abstract Bioactive lipid molecules have been proposed to play important roles linking obesity/metabolic syndrome and cancers. Studies reveal that aberrant metabolic signaling can reprogram cancer cells non-cancer in the tumor microenvironment, contributing initiation, progression, metastasis, recurrence, poor therapeutic response. Existing evidence indicates controlling metabolism be a potential strategy for prevention therapy. By reviewing current literature on various cancers, we summarized major including fatty acids cholesterol as well droplets discussed their critical terms of either promoting- or anti-tumorigenesis. This review provides an overview cellular entities adding existing knowledge with reprogramming immune associated cells. Comprehensive understanding regulatory role microenvironment will provide new direction further studies, shift away from conventional research. Exploring lipid-related targets drive block development may lead novel anti-cancer strategies distinct traditional approaches treatment.

Language: Английский

Citations

25

Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: a preliminary study DOI Creative Commons
Liying Gu, Chunyang Feng, Meng Li

et al.

European journal of medical research, Journal Year: 2023, Volume and Issue: 28(1)

Published: Sept. 7, 2023

Cervical cancer the fourth most frequently diagnosed and leading cause of death in women, with an estimated 604,000 new cases 342,000 deaths worldwide 2020 for high rates recurrence metastasis. Identification novel targets could aid prediction treatment cervical cancer. NADPH oxidase 1 (NOX1) gene-mediated production reactive oxygen species (ROS) induce migration invasion cells. Tumor-associated macrophages (TAMs) play important roles Tumor cell-derived exosomes mediate signal transduction between tumor microenvironment. Elucidation mechanisms NOX1-carrying involved regulation TAMs may provide valuable insights into progression cancer.Uniformly standardized mRNA data pan-carcinoma from UCSC database were downloaded. Expression NOX1 adjacent normal tissues each type was calculated using R language software significant differences analyzed. SNP set downloaded all TCGA samples processed MuTect2 GDC. Cell experiment animal formation used to evaluate whether exosomal stimulating ROS promote M2 polarization TAM cancer.NOX1 is highly expressed a low mutational frequency pan-carcinoma. Upregulation be associated infiltration M2-type tissues, promotes malignant features cells by production. Exosomal enhances vivo production.Exosomal polarization-mediated through

Language: Английский

Citations

13

Precision Oncology: A Method to Maximize Quality of Life DOI

Asma Maheen,

Shuaib Zaidi,

Mohammad Rehan Badar

et al.

Interdisciplinary cancer research, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0

Novel neutrophil targeting platforms in treating Glioblastoma: Latest evidence and therapeutic approaches DOI
Rui Zhong,

Hongmei He,

X Wang

et al.

International Immunopharmacology, Journal Year: 2025, Volume and Issue: 150, P. 114173 - 114173

Published: Feb. 11, 2025

Language: Английский

Citations

0